Cargando…
Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645883/ https://www.ncbi.nlm.nih.gov/pubmed/34704423 http://dx.doi.org/10.24272/j.issn.2095-8137.2021.343 |
| _version_ | 1784610403684188160 |
|---|---|
| author | Xie, Xiaochun Han, Jian-Bao Ma, Guanqin Feng, Xiao-Li Li, Xiaohong Zou, Qing-Cui Deng, Zhong-Hua Zeng, Jianxiong |
| author_facet | Xie, Xiaochun Han, Jian-Bao Ma, Guanqin Feng, Xiao-Li Li, Xiaohong Zou, Qing-Cui Deng, Zhong-Hua Zeng, Jianxiong |
| author_sort | Xie, Xiaochun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8645883 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Science Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86458832021-12-20 Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies Xie, Xiaochun Han, Jian-Bao Ma, Guanqin Feng, Xiao-Li Li, Xiaohong Zou, Qing-Cui Deng, Zhong-Hua Zeng, Jianxiong Zool Res Letter to the Editor Science Press 2021-11-18 /pmc/articles/PMC8645883/ /pubmed/34704423 http://dx.doi.org/10.24272/j.issn.2095-8137.2021.343 Text en Editorial Office of Zoological Research, Kunming Institute of Zoology, Chinese Academy of Sciences https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Xie, Xiaochun Han, Jian-Bao Ma, Guanqin Feng, Xiao-Li Li, Xiaohong Zou, Qing-Cui Deng, Zhong-Hua Zeng, Jianxiong Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies |
| title | Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies |
| title_full | Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies |
| title_fullStr | Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies |
| title_full_unstemmed | Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies |
| title_short | Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies |
| title_sort | emerging sars-cov-2 b.1.621/mu variant is prominently resistant to inactivated vaccine-elicited antibodies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645883/ https://www.ncbi.nlm.nih.gov/pubmed/34704423 http://dx.doi.org/10.24272/j.issn.2095-8137.2021.343 |
| work_keys_str_mv | AT xiexiaochun emergingsarscov2b1621muvariantisprominentlyresistanttoinactivatedvaccineelicitedantibodies AT hanjianbao emergingsarscov2b1621muvariantisprominentlyresistanttoinactivatedvaccineelicitedantibodies AT maguanqin emergingsarscov2b1621muvariantisprominentlyresistanttoinactivatedvaccineelicitedantibodies AT fengxiaoli emergingsarscov2b1621muvariantisprominentlyresistanttoinactivatedvaccineelicitedantibodies AT lixiaohong emergingsarscov2b1621muvariantisprominentlyresistanttoinactivatedvaccineelicitedantibodies AT zouqingcui emergingsarscov2b1621muvariantisprominentlyresistanttoinactivatedvaccineelicitedantibodies AT dengzhonghua emergingsarscov2b1621muvariantisprominentlyresistanttoinactivatedvaccineelicitedantibodies AT zengjianxiong emergingsarscov2b1621muvariantisprominentlyresistanttoinactivatedvaccineelicitedantibodies |